KIRN DAVID (See Remarks) sold 6.2% of their position (58.33K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $737.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/14/2026ACC: 0001834021-26-000004
DirectorOfficer10% Owner· See Remarks
Since Dec 2020
-58.33K
Net shares
Net seller
$737.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
58.33K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−42.61K
Price / share
$12.87
Trade value
$548.18K
% of position
4.5%
7/9/2026
942.49K→899.88K
Common Stock
Direct
Shares
−15.28K
Price / share
$12.01
Trade value
$183.56K
% of position
1.7%
7/10/2026
899.88K→884.59K
Common Stock
Direct
Shares
−442.00
Price / share
$12.84
Trade value
$5.67K
% of position
0.0%
7/10/2026
884.59K→884.15K
Total
Net shares
−58.33K
Net value
-$737.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2026 | S · Sale | −42.61K | $12.87 | $548.18K | 4.5% | 942.49K | 899.88K |
| Common Stock Direct | 7/10/2026 | S · Sale | −15.28K | $12.01 | $183.56K | 1.7% | 899.88K | 884.59K |
| Common Stock Direct | 7/10/2026 | S · Sale | −442.00 | $12.84 | $5.67K | 0.0% | 884.59K | 884.15K |
| Total | −58.33K | -$737.41K | ||||||
Derivative Transactions0
No derivative transactions reported